Hypogonadism and Sex Steroid Replacement Therapy in Girls with Turner Syndrome.
暂无分享,去创建一个
P. Madej | A. Drosdzol-Cop | A. Gawlik | E. Malecka-Tendera | A. Zachurzok | Magdalena Hankus | Marzena Borkowska | Kamila Such
[1] V. Montori,et al. Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. , 2015, The Journal of clinical endocrinology and metabolism.
[2] M. Bagłaj,et al. Risk of Malignancy and Need for Surgery in Pediatric Patients with Morris or Y-chromosome Turner Syndrome: A Multicenter Survey. , 2015, Journal of pediatric and adolescent gynecology.
[3] S. Poyrazoglu,et al. Increased arterial stiffness in young normotensive patients with Turner syndrome: associations with vascular biomarkers , 2015, Clinical endocrinology.
[4] F. Camassei,et al. Ullrich–Turner Syndrome and Tumor Risk: Is There Another Chance to Early Gonadectomy in Positive TSPY and SRY Patients? , 2015, European Journal of Pediatric Surgery.
[5] M. Gass,et al. The North American Menopause Society recommendations for clinical care of midlife women. , 2014, Menopause.
[6] E. Urbina,et al. Vasculopathy in the young Turner syndrome population. , 2014, The Journal of clinical endocrinology and metabolism.
[7] J. Ross,et al. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial. , 2014, The Journal of clinical endocrinology and metabolism.
[8] T. Irzyniec,et al. The influence of hormonal replacement and growth hormone treatment on the lipids in Turner syndrome , 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[9] O. Harmanli,et al. Obstetrician-gynecologists’ opinions on elective bilateral oophorectomy at the time of hysterectomy in the United States: a nationwide survey , 2013, Menopause.
[10] F. Rosendaal,et al. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy , 2013, Journal of thrombosis and haemostasis : JTH.
[11] I. Rica,et al. Individualised vs fixed dose of oral 17β-oestradiol for induction of puberty in girls with Turner syndrome: an open-randomised parallel trial. , 2012, European journal of endocrinology.
[12] H. Elsedfy,et al. Uterine development in patients with Turner syndrome: Relation to hormone replacement therapy and karyotype , 2012, Journal of pediatric endocrinology & metabolism : JPEM.
[13] C. Gravholt,et al. Coagulation and fibrinolytic disturbances are related to carotid intima thickness and arterial blood pressure in Turner syndrome , 2012, Clinical endocrinology.
[14] A. Gawlik,et al. Quality of Medical Follow-Up of Young Women with Turner Syndrome Treated in One Clinical Center , 2012, Hormone Research in Paediatrics.
[15] C. Gravholt,et al. Sex hormone replacement in Turner syndrome , 2012, Endocrine.
[16] Y. Nishio,et al. Estrogen therapy initiated at an early age increases bone mineral density in Turner syndrome patients. , 2012, Endocrine journal.
[17] N. Mauras,et al. Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndrome. , 2011, The Journal of clinical endocrinology and metabolism.
[18] J. Timmermans,et al. Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome. , 2011, The Journal of clinical endocrinology and metabolism.
[19] A. Andersson,et al. Uterus and ovaries in girls and young women with Turner syndrome evaluated by ultrasound and magnetic resonance imaging , 2011, Clinical endocrinology.
[20] S. Taback,et al. Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone , 2011, BMC pediatrics.
[21] T. Cole,et al. Effect of oxandrolone and timing of pubertal induction on final height in Turner’s syndrome: randomised, double blind, placebo controlled trial , 2011, BMJ : British Medical Journal.
[22] D. Botsis,et al. Response to hormonal treatment of young females with primary or very premature ovarian failure , 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[23] M. Roček,et al. Bone geometry and volumetric bone mineral density in girls with Turner syndrome of different pubertal stages , 2011, Clinical endocrinology.
[24] D. Cao,et al. Growth hormone plus childhood low-dose estrogen in Turner's syndrome. , 2011, The New England journal of medicine.
[25] K. Main,et al. FSH, LH, inhibin B and estradiol levels in Turner syndrome depend on age and karyotype: longitudinal study of 70 Turner girls with or without spontaneous puberty. , 2010, Human reproduction.
[26] K. Main,et al. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. , 2010, The Journal of clinical endocrinology and metabolism.
[27] S. Ten,et al. Markers of ovarian reserve in young girls with Turner's syndrome. , 2010, Fertility and sterility.
[28] M. Whitehead,et al. The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy , 2010, Journal of thrombosis and haemostasis : JTH.
[29] S. Suissa,et al. Hormone replacement therapy and the risk of venous thromboembolism: a population‐based study , 2010, Journal of thrombosis and haemostasis : JTH.
[30] J. Aharon-Peretz,et al. Androgen replacement therapy in Turner syndrome: a pilot study. , 2009, The Journal of clinical endocrinology and metabolism.
[31] C. Gravholt,et al. Ambulatory Arterial Stiffness Index in Turner Syndrome: The Impact of Sex Hormone Replacement Therapy , 2009, Hormone Research in Paediatrics.
[32] L. Mosekilde,et al. Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome. , 2009, European journal of endocrinology.
[33] L. Dimeglio,et al. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study. , 2009, The Journal of clinical endocrinology and metabolism.
[34] Thomas W. Kelsey,et al. Human Ovarian Reserve from Conception to the Menopause , 2009, PloS one.
[35] S. van Buuren,et al. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels , 2009, Clinical endocrinology.
[36] O. Koulouri,et al. Liver dysfunction in Turner's syndrome: prevalence, natural history and effect of exogenous oestrogen , 2008, Clinical endocrinology.
[37] N. Mauras,et al. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome. , 2007, The Journal of clinical endocrinology and metabolism.
[38] T. Shawker,et al. Uterine development in Turner syndrome. , 2007, The Journal of pediatrics.
[39] C. Gravholt,et al. Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. , 2007, European journal of endocrinology.
[40] G. Conway,et al. A dose‐response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism , 2007, Clinical endocrinology.
[41] E. Oger,et al. Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study , 2007, Circulation.
[42] Svend Juul,et al. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. , 2006, The Journal of clinical endocrinology and metabolism.
[43] D. Moskowitz. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks. , 2006, Alternative medicine review : a journal of clinical therapeutic.
[44] D. Chrysis,et al. Gonadotropin Secretion in Girls with Turner Syndrome Measured by an Ultrasensitive Immunochemiluminometric Assay , 2006, Hormone Research in Paediatrics.
[45] J. Ross,et al. Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. , 2006, JAMA.
[46] M. Guimarães,et al. Insulin resistance and body composition in Turner syndrome: Effect of sequential change in the route of estrogen administration , 2006, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[47] B. Biesecker,et al. Turner syndrome: Four challenges across the lifespan , 2005, American journal of medical genetics. Part A.
[48] N. Mauras,et al. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. , 2005, The Journal of clinical endocrinology and metabolism.
[49] J. Coste,et al. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. , 2005, The Journal of clinical endocrinology and metabolism.
[50] M. Ranke,et al. Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001. , 2005, Human reproduction.
[51] P. Kainulainen,et al. Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome. , 2004, The Journal of clinical endocrinology and metabolism.
[52] M. Šnajderová,et al. The Uterine Length in Women with Turner Syndrome Reflects the Postmenarcheal Daily Estrogen Dose , 2003, Hormone Research in Paediatrics.
[53] C. McDonnell,et al. A 3‐year prospective study to assess uterine growth in girls with Turner's syndrome by pelvic ultrasound , 2003, Clinical endocrinology.
[54] B. Fauser,et al. Antimüllerian hormone serum levels: a putative marker for ovarian aging. , 2002, Fertility and sterility.
[55] C. Ankarberg-Lindgren,et al. Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. , 2001, The Journal of clinical endocrinology and metabolism.
[56] O. Hovatta. Pregnancies in women with Turner's syndrome. , 1999, Annals of medicine.
[57] M. Segni,et al. Spontaneous Pubertal Development in Turner’s Syndrome , 1997 .
[58] T. G. Baker. A quantitative and cytological study of germ cells in human ovaries , 1963, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[59] C. Ankarberg-Lindgren,et al. Sex Steroid Replacement Therapy in Female Hypogonadism from Childhood to Young Adulthood. , 2016, Endocrine development.
[60] T. Lumley,et al. Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens. , 2014, JAMA internal medicine.
[61] C. Bondy,et al. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. , 2007, The Journal of clinical endocrinology and metabolism.
[62] H. Raat,et al. Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome. , 2006, The Journal of pediatrics.
[63] R. Williams,et al. Williams Textbook of endocrinology , 1985 .